Vicki Moore, PhD

Contributing Writer https://www.clinicaladvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Oncology Information Center

Neoadjuvant Nivolumab-Ipilimumab Could Be New Standard Care in dMMR Colon Cancer

Vicki Moore, PhD

October 5, 2022

Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.

Oncology Information Center

Assessing Priorities in End-of-Life Care for Children With Cancer

Vicki Moore, PhD

October 25, 2021

In a study of end-of-life care for children with cancer, healthcare resource use measures were seen as less important than were patient-reported outcomes.

Depression is experienced by many patients after a cancer diagnosis.

Mood Disorder Information Center

Nursing Strategies for Managing Depression in Patients With Cancer

Vicki Moore, PhD

August 30, 2021

Researchers review effective strategies for screening, assessment, and management of depression in patients with cancer.

Risk-stratification technology is evolving in chronic lymphocytic leukemia and can be used to guide treatment decisions and direct patients to clinical trials.

Oncology Information Center

Unique Nurse Role for Managing Outpatient Care Throughout Chimeric Antigen Receptor T-Cell Therapy

Vicki Moore, PhD

August 25, 2021

A report examines a newly created role in nursing care for managing patient care during chimeric antigen receptor T-cell therapy in the outpatient setting.

Nurse tending patient in intensive care.

Oncology Information Center

Infection Risk for Patients With Myeloproliferative Neoplasms

Vicki Moore, PhD

August 4, 2021

Matched cohort study showed risk greatest for those with primary myelofibrosis, but still high for those with polycythemia vera and essential thrombocythemia.